HCPCS Level IIdrugActive
J9325
Inj talimogene laherparepvec
BETOS: O1E
Effective: 2017-01-01
Description
Injection, talimogene laherparepvec, per 1 million plaque forming units
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Imlygic
Manufacturer
Amgen Inc
HCPCS Dosage
1 million PFU
Billing Units
1.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.